Sarma Nilendu
Department of Dermatology, Dr B. C. Roy Post Graduate Institute of Pediatric Sciences, Kolkata, West Bengal, India.
Indian J Dermatol. 2017 Mar-Apr;62(2):113-122. doi: 10.4103/ijd.IJD_539_16.
Psoriasis is resistant to treatment and it shows frequent relapse; systemic treatment is often associated with toxicities, and long-term safety data are lacking for most of the newer drugs like biologics. Moreover, some body areas such as hands, feet, intertriginous areas, scalp, and nails are even more resistant. Frequently, systemic treatments are necessary considering the higher psychological impact on the patient. There is a lack of agreement on the best therapeutic modalities in the management of psoriasis involving difficult-to-treat locations. At present, there are no Indian guidelines for these conditions. Available literature has been reviewed extensively on the treatment of psoriasis involving difficult-to-treat locations; level of evidence has been evaluated as per the Oxford Centre for Evidence-Based Medicine 2011 guideline, and therapeutic suggestions have been developed. Best care has been employed to consider socioeconomic, cultural, genetic, and ethnic factors to prepare a therapeutic suggestion that is appropriate and logical to be used among Indian population and people of similar ethnic and socioeconomic background.
银屑病治疗困难且易复发;全身治疗常伴有毒性,大多数新型药物如生物制剂缺乏长期安全性数据。此外,一些身体部位如手部、足部、褶皱部位、头皮和指甲对治疗更具抗性。通常,考虑到对患者更高的心理影响,全身治疗是必要的。在银屑病累及难治部位的管理中,对于最佳治疗方式缺乏共识。目前,印度尚无针对这些情况的指南。已广泛回顾了关于银屑病累及难治部位治疗的现有文献;根据牛津循证医学中心2011年指南评估了证据水平,并制定了治疗建议。已尽最大努力考虑社会经济、文化、遗传和种族因素,以制定出适合印度人群以及具有相似种族和社会经济背景人群使用的合理治疗建议。